Orthofix Medical Inc (OFIX) Insider Sells $23,850.81 in Stock

Orthofix Medical Inc (NASDAQ:OFIX) insider Bradley V. Niemann sold 387 shares of the company’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $61.63, for a total transaction of $23,850.81. Following the completion of the sale, the insider now directly owns 25,748 shares in the company, valued at $1,586,849.24. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Shares of NASDAQ:OFIX traded down $0.45 during midday trading on Friday, reaching $61.92. The company’s stock had a trading volume of 1,649 shares, compared to its average volume of 192,190. The company has a market capitalization of $1.15 billion, a PE ratio of 38.25, a P/E/G ratio of 3.59 and a beta of 0.30. Orthofix Medical Inc has a 12-month low of $50.41 and a 12-month high of $63.57.

Orthofix Medical (NASDAQ:OFIX) last released its earnings results on Monday, October 29th. The medical device company reported $0.43 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.34 by $0.09. The firm had revenue of $111.70 million for the quarter, compared to the consensus estimate of $110.65 million. Orthofix Medical had a net margin of 1.45% and a return on equity of 10.97%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.42 EPS. As a group, analysts expect that Orthofix Medical Inc will post 1.75 EPS for the current fiscal year.

A number of analysts have recently weighed in on OFIX shares. BidaskClub downgraded shares of Orthofix Medical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, September 12th. Zacks Investment Research downgraded shares of Orthofix Medical from a “hold” rating to a “sell” rating in a research report on Thursday, August 9th. TheStreet downgraded shares of Orthofix Medical from a “b” rating to a “c+” rating in a research report on Wednesday, August 1st. Finally, Cantor Fitzgerald upped their target price on shares of Orthofix Medical to $66.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 7th. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $67.67.

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in Orthofix Medical by 4.3% in the 2nd quarter. BlackRock Inc. now owns 2,766,105 shares of the medical device company’s stock worth $157,170,000 after purchasing an additional 112,878 shares in the last quarter. Paradice Investment Management LLC boosted its stake in Orthofix Medical by 26.3% in the 3rd quarter. Paradice Investment Management LLC now owns 376,618 shares of the medical device company’s stock worth $21,772,000 after purchasing an additional 78,499 shares in the last quarter. First Trust Advisors LP bought a new position in Orthofix Medical in the 2nd quarter worth about $3,006,000. Fort Washington Investment Advisors Inc. OH boosted its stake in Orthofix Medical by 14.3% in the 3rd quarter. Fort Washington Investment Advisors Inc. OH now owns 358,689 shares of the medical device company’s stock worth $20,736,000 after purchasing an additional 44,993 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Orthofix Medical by 487.2% in the 3rd quarter. SG Americas Securities LLC now owns 37,901 shares of the medical device company’s stock worth $2,191,000 after purchasing an additional 31,446 shares in the last quarter. 92.64% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Orthofix Medical Inc (OFIX) Insider Sells $23,850.81 in Stock” was first posted by WKRB News and is the sole property of of WKRB News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.wkrb13.com/2018/11/09/orthofix-medical-inc-ofix-insider-sells-23850-81-in-stock.html.

About Orthofix Medical

Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Read More: Price to Earnings Ratio (PE), For Valuing Stocks

Insider Buying and Selling by Quarter for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply